Nextran
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nextran
Roslin Bio-Med Ltd.
Can Dolly the sheep bring home the bacon? Roslin Bio-Med has licensed nuclear transfer technology from the Roslin Institute to develop transgenic pigs from which the start-up hopes to obtain organs for transplant and blood products.
BioTransplant: Turned on to Tolerance
Thousands die each year of end-stage organ failure. Transplantation is the preferred therapy, but there is a chronic shortage of human organs and organ rejection remains a problem. Bringing xenotransplantation to market has become a big company affair, but BioTransplant is a biotech still looking to win a piece of the market through an unusual partnership and unique technology.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice